BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10517190)

  • 21. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
    Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
    Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neutropenia and sepsis in hematologic patients].
    Egyed M; Kollár B; Karádi E; Rajnics P; Kocsondi L; Rumi G
    Orv Hetil; 2006 Oct; 147(42):2031-3. PubMed ID: 17165603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective search for ocular lesions in hospitalized patients with significant bacteremia.
    Bouza E; Cobo-Soriano R; Rodríguez-Créixems M; Muñoz P; Suárez-Leoz M; Cortés C
    Clin Infect Dis; 2000 Feb; 30(2):306-12. PubMed ID: 10671333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
    Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston KV; Kontoyiannis DP; Galanakis E; Samonis G
    Infection; 2004 Apr; 32(2):65-71. PubMed ID: 15057569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996.
    Crowe M; Ispahani P; Humphreys H; Kelley T; Winter R
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):377-84. PubMed ID: 9758274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies.
    Samonis G; Vardakas KZ; Maraki S; Tansarli GS; Dimopoulou D; Kofteridis DP; Andrianaki AM; Falagas ME
    Support Care Cancer; 2013 Sep; 21(9):2521-6. PubMed ID: 23625018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
    Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
    J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer.
    Paganini HR; Aguirre C; Puppa G; Garbini C; Ruiz Guiñazú J; Ensinck G; Vrátnica C; Flynn L; Iacono M; Zubizarreta P;
    Cancer; 2007 Jun; 109(12):2572-9. PubMed ID: 17492687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
    J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gram-negative bacteremia in non-neutropenic patients: a 3-year review.
    Gikas A; Samonis G; Christidou A; Papadakis J; Kofteridis D; Tselentis Y; Tsaparas N
    Infection; 1998; 26(3):155-9. PubMed ID: 9646106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years].
    Ruiz-Giardín JM; Noguerado A; Pizarro A; Méndez J; La Hulla F; Fernández M; Hernández F; San Martín JV; Hernández I; Alvarez J; Salvanes F
    Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):435-42. PubMed ID: 12425877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
    Abidi MZ; Ledeboer N; Banerjee A; Hari P
    Diagn Microbiol Infect Dis; 2016 May; 85(1):116-20. PubMed ID: 26906191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gram-negative rod bacteremia after cardiovascular surgery: Clinical features and prognostic factors.
    Tago S; Hirai Y; Ainoda Y; Fujita T; Kikuchi K
    J Microbiol Immunol Infect; 2017 Jun; 50(3):333-338. PubMed ID: 26323362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
    Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
    Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution.
    González-Barca E; Fernández-Sevilla A; Carratalá J; Grañena A; Gudiol F
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):291-6. PubMed ID: 8781879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
    Cherif H; Kronvall G; Björkholm M; Kalin M
    Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.